BioRestorative Therapies (BRTX) Net Equity Issued and Repurchased (2010 - 2026)
BioRestorative Therapies' Net Equity Issued and Repurchased came in at $5 million for Q1 2026, up 343.9% from $1.13 million a year earlier and up 361.4% from the prior quarter.
BioRestorative Therapies (BRTX) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, BioRestorative Therapies reported Net Equity Issued and Repurchased of $7.01 million, down 19.8% year-over-year; for FY2025, it came in at $3.14 million, up 246.3% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 215.7% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $906,000 in FY2024 (-61.4%), $2.35 million in FY2023 and $21.07 million in FY2021.
- The Q1 2026 figure represents the highest quarterly Net Equity Issued and Repurchased since Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 | 5.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Jun 30, 2025 | 927,335.00 |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | -6.62 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Dec 31, 2023 | 83,073.00 |
| Sep 30, 2023 | 1.85 Mn |
| Mar 31, 2020 | 10,000.00 |
| Dec 31, 2019 | 502,500.00 |
| Jun 30, 2019 | 556,000.00 |
| Mar 31, 2019 | 600,000.00 |
| Sep 30, 2018 | 150,000.00 |
| Jun 30, 2018 | 25,000.00 |
| Mar 31, 2018 | 414,168.00 |
| Dec 31, 2017 | 881,250.00 |
| Sep 30, 2017 | 30,000.00 |
| Jun 30, 2017 | 84,000.00 |
| Mar 31, 2017 | 1.09 Mn |
| Dec 31, 2016 | 367,068.00 |
BioRestorative Therapies Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BRTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();